Drug Discovery & Development

Drug-manufacturing bacteria can provide a more targeted approach to treat gut diseases.

Alayna Loiselle has found a way to bring therapeutics straight to an injured tendon.

Jingjing Sun developed a novel, ultra-small nanocarrier that actively targets tumor cells.

As kinase dysfunction underlies many pathological conditions, scientists require high-quality active kinases for their therapeutic development programs.

Microfluidic technology enables high-throughput, droplet-based antibody discovery in fully human antibody mice.

As the world grapples with antimicrobial-resistant bacteria, another insidious threat looms large: drug-resistant fungi.

Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.

Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases

Researchers easily separate chiral and achiral compounds for drug analysis and purification.

Researchers ensure the success of their serial dilution-based assays by using optimized protocols and advanced liquid handling tools.

Learn how scientists examine mRNA quality using an easy-to-operate LC-MS system.

Learn how cutting-edge strategies empower researchers to target undruggable proteins.

The SmartChip ND system meets laboratories’ needs for flexibility, scalability, efficiency, and affordability.

A novel compound targets an essential transport system found only in disease-causing bacteria, leaving commensal bacteria unharmed. 

Nathalie Fuentes shared her experience of landing a unicorn position in a pharmaceutical company after a postdoctoral fellowship.

Harnessing the capabilities of the PhysioMimix Multi-organ System, the kit enhances lead optimization and preclinical testing pipelines, providing an all-in-one solution to generate predictive insights into human oral bioavailability, and better inform lead candidate selection.

Collaboration enables customers to securely and confidently use AI to accelerate drug research and discovery.

Discover how a precise, high-throughput proteomics assay enables researchers to uncover previously unidentified biomarkers.